Search company, investor...

Stage

Divestiture

Total Raised

$26M

Investors Count

5

Deal Terms

6

Portfolio Exits

4

Funding, Valuation & Revenue

9 Fundings

Tabula Rasa Healthcare has raised $26M over 9 rounds.

Tabula Rasa Healthcare's latest funding round was a Take Private for on November 6, 2023.

Tabula Rasa Healthcare's valuation in September 2016 was $186.1M.

Tabula Rasa Healthcare's latest post-money valuation is from November 2023.

Sign up for a free demo to see Tabula Rasa Healthcare's valuations in November 2023, September 2013 and more.

Tabula Rasa Healthcare's 2015 revenue was $42.57M. Tabula Rasa Healthcare's most recent revenue is from 2015.

Sign up for a free demo to see revenue data from 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/6/2023

Take Private

$99M

0

FY undefined

2

9/29/2016

IPO

$99M

$186.1M

$0.00B

((9.99x))

FY 1234

10

1/1/2015

Debt - III

$99M

$99M

$42.57M

FY 2015

0

5/1/2014

Debt - II

$99M

$99M

$0.00B

((9.99x))

FY 1234

0

9/12/2013

Series B

$99M

$99M

0

FY undefined

10

Date

11/6/2023

9/29/2016

1/1/2015

5/1/2014

9/12/2013

Round

Take Private

IPO

Debt - III

Debt - II

Series B

Amount

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$186.1M

$99M

$99M

$99M

Revenue

0

FY undefined

$0.00B

((9.99x))

FY 1234

$42.57M

FY 2015

$0.00B

((9.99x))

FY 1234

0

FY undefined

Sources

2

10

0

0

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Tabula Rasa Healthcare Deal Terms

6 Deal Terms

Tabula Rasa Healthcare's deal structure is available for 6 funding rounds, including their Take Private from November 06, 2023.

Round

Take Private

IPO

Series B

Series A - II

Series A

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Take Private

$99M

$99M

$99M

$99M

IPO

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Tabula Rasa Healthcare Investors

5 Investors

Tabula Rasa Healthcare has 5 investors. Nautic Partners invested in Tabula Rasa Healthcare's Take Private funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/6/2023

11/6/2023

1
Take Private

Private Equity

Rhode Island

00/00/0000

00/00/0000

Eastward Capital Partners

Subscribe to see more

Debt & Specialty Finance

Massachusetts

00/00/0000

00/00/0000

Radius Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Originate Ventures

Subscribe to see more

Venture Capital

Pennsylvania

00/00/0000

00/00/0000

Rittenhouse Ventures

Subscribe to see more

Venture Capital

Pennsylvania

First funding

11/6/2023

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/6/2023

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Eastward Capital Partners

Radius Ventures

Originate Ventures

Rittenhouse Ventures

Rounds

1
Take Private

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Private Equity

Debt & Specialty Finance

Venture Capital

Venture Capital

Venture Capital

Location

Rhode Island

Massachusetts

New York

Pennsylvania

Pennsylvania

Tabula Rasa Healthcare Acquisitions

6 Acquisitions

Tabula Rasa Healthcare acquired 6 companies. Their latest acquisition was eClusive on August 07, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/7/2019

$99M

Acquired

1

3/5/2019

Seed / Angel

Subscribe to see more

$99M

$99M

Subscribe to see more

10

12/3/2018

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

10

11/8/2018

Subscribe to see more

$99M

Subscribe to see more

10

9/4/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/7/2019

3/5/2019

12/3/2018

11/8/2018

9/4/2018

Investment Stage

Seed / Angel

Series A

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Tabula Rasa Healthcare Portfolio Exits

4 Portfolio Exits

Tabula Rasa Healthcare has 4 portfolio exits. Their latest portfolio exit was SinfoniaRx on March 02, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/2/2023

Divestiture

$99M

1/20/2023

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

6/21/2022

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

6/21/2022

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/2/2023

1/20/2023

6/21/2022

6/21/2022

Exit

Divestiture

Divestiture

Divestiture

Divestiture

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

10

10

10

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Tabula Rasa Healthcare to Competitors

M
MDI Health

MDI Health develops a framework for artificial pharmacology intelligence. The company uses technology, methodology, and algorithms to ensure early detection of potential medication-related problems (MRPs) during a drug treatment regimen. It is an add-on to electronic health records systems (EHRs) supporting physicians, helping them make more informed medication-related decisions, and providing personalized multi-drug treatment. The company was founded in 2019 and is based in Tel Aviv, Israel.

P
Pharmesol

Pharmesol is an artificial intelligence (AI)--enabled company focused on the healthcare and pharmaceutical industry. The company offers an automated assistant for pharmacies, designed to handle frequent conversations and administrative tasks, thereby improving patient experience. Its primary market is the healthcare industry. It was founded in 2023 and is based in Auburndale, Massachusetts.

Arine Logo
Arine

Arine offers a healthcare software platform. The company combines healthcare and behavioral data to identify treatment gaps, optimize regimes, reduce errors, and improve health outcomes through its artificial intelligence (AI) powered virtual pharmacist software platform. Arine was formerly known as Akeso. The company was founded in 2019 and is based in San Francisco, California.

RxAnte Logo
RxAnte

RxAnte is a company that focuses on predictive analytics and clinical services in the healthcare industry. The company offers solutions that improve medication use and health outcomes, including patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, and a web-based workflow solution. RxAnte primarily serves health plans and providers. It was founded in 2011 and is based in Portland, Maine. RxAnte operates as a subsidiary of Millennium Laboratories.

AdhereHealth Logo
AdhereHealth

AdhereHealth is a technology company that operates in the healthcare sector. The company's main offerings include a platform that uses advanced analytics to improve medication adherence, aiming to reduce unnecessary medical costs. This platform, delivered as tech-enabled telepharmacy services or Software-as-a-Service (SaaS), supports better clinical outcomes, patient experience, and medical cost avoidance. AdhereHealth primarily sells to health plans, self-insured employers, and other risk-bearing entities. AdhereHealth was formerly known as PharmMD. It is based in Brentwood, Tennessee.

T
Translational Software

Translational Software is a company focused on the healthcare sector, specifically in the field of precision medicine. The company's main service was to simplify complex genetic data into evidence-based actionable recommendations, primarily in the form of pharmacogenomics testing. However, due to changing regulations, the company has ceased offering these solutions in the U.S. market. It was founded in 2009 and is based in Bellevue, Washington.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.